David L. Crandall

Tiplaxtinin, a Novel, Orally Efficacious Inhibitor of Plasminogen Activator Inhibitor-1:  Design, Synthesis, and Preclinical Characterization

Hassan Elokdah, Magid Abou‐Gharbia, James K. Hennan et al. · Journal of Medicinal Chemistry · 2004 · 166 citations · Full text

Pharmaceutical Science, Antiparasitic Agent, Cardiovascular Pharmacology +20

Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade

J. Steven Jacobsen, Thomas A. Comery, Robert Martone et al. · Proceedings of the National Academy of Sciences · 2008 · 136 citations · Full text

Neurochemical Biomarkers, Social Sciences, Enhanced Clearance +21

Identification of Estrogen Receptor β RNA in Human Breast and Abdominal Subcutaneous Adipose Tissue

David L. Crandall, Dennis E. Busler, Thomas J. Novak et al. · Biochemical and Biophysical Research Communications · 1998 · 112 citations

Human Breast, Systems Biology, Endocrine Mechanism +10

Pharmacological Inhibition and Genetic Deficiency of Plasminogen Activator Inhibitor-1 Attenuates Angiotensin II/Salt-Induced Aortic Remodeling

Alec D. Weisberg, Francisco Albornoz, Jane P. Griffin et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 109 citations

PDGFβ Receptor Blockade Inhibits Intimal Hyperplasia in the Baboon

Charles E. Hart, Larry W. Kraiss, Selina Vergel et al. · Circulation · 1999 · 101 citations · Full text